Themis Medicare Limited -5.79 % Pharmaceuticals

Trend Analysis

Loading...

Support and Resistance Levels Analysis
The current close value 232.1 is between the support and resistance channel of 222 and 242. The stock has a Sell Signal , 222 becomes a critical support to stop the fall and 242 is a immediate resistance on the upside.

Technical Indicators (3 Month duration)
Exponential Moving average 237.5
MACD value -8.8
Price range 224.25 to 309.15
Volume range 187 to 1607
Support & Resistance 222, 242
Stock Performance
Six Months -29.9%
Five Months-18.9%
Four Months-21.3%
Three Months-19.3%
Two Months-17.7%
One Month-8.1%
Last Six Months

-29.9%

Last Five Months

-18.9%

Last Four Months

-21.3%

Last Three Months

-19.3%

Last Two Months

-17.7%

Last One Month

-8.1%

Analysis
Volume
Today's Price Range
3 Month Price Range
About Themis Medicare Limited
Themis Medicare Limited is an India-based joint venture pharmaceutical company, with Gedeon Richter Ltd., Hungary. The Company manufactures and markets pharmaceutical products. Active pharmaceutical ingredients account for a significant portion of Themis Medicare's revenue. Themis Medicare has manufacturing facilities at three locations, in Vapi (Gujarat), Hyderabad (Andhra Pradesh), and Haridwar (Uttaranchal). The company is also engaged in therapeutic areas like anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, Health & Nutrition. The company is also engaged in co-marketing its research based formulations with other pharmaceutical companies in India and abroad. Themis Medicare has portfolio of affiliates across the globe with a presence in 40 countries. Themis Medicare's active pharmaceutical ingredients (API) include Simvastatin and Di Methyl Isosorbide.
See stocks similar to Themis Medicare Limited in Pharmaceuticals

Themis Medicare Limited has Sell Signal. What is your opinion on it?

{ }